Artistmss Intl Group Inc (AIGI)

[vulken17]

The joint venture will prove profitable for both companies. check out: interesting website

http://www.primepharmaceutical.com/

Prime’s unique extraction process presents promising out-licensing opportunities, as it will allow other plant-based manufacturers to enhance their extracts.

The company has acquired the Canadian license to the dermatological use of a new class of antioxidant compounds, Azeul Nitrones, which hold great promise of slowing down the negative results of ageing skin.

Prime owns the worldwide rights to a breakthrough micro-sphere particle technology for dermatological and cosmetic applications. This technology has many advantages over other biotechnology delivery systems used in topical formulations and can offer improvements to many existing pharmaceuticals and cosmetics as well as make possible the formulation of new and more effective treatments.

Prime is financing a joint biotech research program with Memorial University in Newfoundland, which is focused on creating a new molecule that is effective in treating skin, and other diseases, that are characterized by inflammation and rapid cell proliferation. In recent history, new molecules that result in new drugs such as Tiazac (Biovail) An-1792 (Elan), Viagra (Pfizer), and Celexa (Forest Labs) have proven to be of significant commercial success.

Prime has ensured a long-term source of scientific technology through a strategic alliance with Utek Corporation, a Florida based, technology transfer company. Utek (UTK) is a public company listed on the American Stock Exchange, which has entered into an agreement whereby they will source and introduce appropriate technology acquisition opportunities for Prime. Utek, with its advisory board of 18 scientists, of which 3 are Nobel prizewinners, has recognized the huge potential of Prime Pharmaceutical Corporation and made a substantial equity investment in the company.